betaine has been researched along with Hepatitis in 4 studies
glycine betaine : The amino acid betaine derived from glycine.
Hepatitis: INFLAMMATION of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine is a safe and well tolerated drug that leads to a significant biochemical and histological improvement in patients with NASH." | 6.70 | Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. ( Abdelmalek, MF; Angulo, P; Jorgensen, RA; Lindor, KD; Sylvestre, PB, 2001) |
| "Betaine is a safe and well tolerated drug that leads to a significant biochemical and histological improvement in patients with NASH." | 2.70 | Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. ( Abdelmalek, MF; Angulo, P; Jorgensen, RA; Lindor, KD; Sylvestre, PB, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ASTRUP, P | 1 |
| Neuschwander-Tetri, BA | 1 |
| Abdelmalek, MF | 1 |
| Angulo, P | 1 |
| Jorgensen, RA | 1 |
| Sylvestre, PB | 1 |
| Lindor, KD | 1 |
| Cachin, M | 1 |
| Pergola, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF[NCT00406536] | Phase 2 | 110 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| Comparison of Standard Therapy,Peginterferon Alpha-2a + Ribavirin for 48 Weeks VS Peginterferon Alph-2a + Ribavirin + Betaine for 12 Weeks Followed by 36 Weeks Standard Therapy in Untreated Adults With Chronic Hepatitis C Genotype 1[NCT00571714] | 0 participants (Actual) | Interventional | 2008-04-01 | Withdrawn (stopped due to lack of enrollment) | |||
| Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria[NCT00283387] | Phase 2 | 15 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The patients were randomly assigned oral betaine or placebo for 2 months, followed by a 2 month washout. Each patient then received the alternate study medication for 2 months.~Urinary Oxalate Excretion was measured by oxalate oxidase. Two 24 hour urine collections were obtained at baseline, and during the eighth week of each study period." (NCT00283387)
Timeframe: baseline, 2 months, 6 months
| Intervention | umol/mg (Mean) |
|---|---|
| Betaine | 1.43 |
| Placebo | 1.04 |
1 trial available for betaine and Hepatitis
| Article | Year |
|---|---|
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Topics: Adult; Betaine; Fatty Liver; Female; Hepatitis; Humans; Lipotropic Agents; Male; Middle Aged; Pilot | 2001 |
3 other studies available for betaine and Hepatitis
| Article | Year |
|---|---|
On the effect of betaine on the course of hepatitis acuta.
Topics: Betaine; Hepatitis; Hepatitis A | 1948 |
Betaine: an old therapy for a new scourge.
Topics: Betaine; Fatty Liver; Hepatitis; Humans; Lipotropic Agents; Methylation | 2001 |
[Betaine aspartate in the hepato-digestive domain].
Topics: Aspartic Acid; Betaine; Dyspepsia; Fatty Liver; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; | 1966 |